Clinical trial
A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
NCT00196404 is registered in ClinicalTrials.gov with Duramed Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
- Lead sponsor
- Duramed Research
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- December 31, 2006
- Enrollment
- 800 (estimated)
- Sites
- 48
Conditions
As the registry lists them; a condition with its own page is linked.